Eccrine squamous syringometaplasia. A cutaneous sweat gland reaction in the histologic spectrum of 'chemotherapy-associated eccrine hidradenitis' and 'neutrophilic eccrine hidradenitis'

Ma, Hurt; Rd, Halvorson; Fc, Petr; Jt, Cooper; Dj, Friedman

doi:10.1001/archderm.126.1.73

Cited by 69 publications

(46 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Des cas de SMN de localisation atypique ont été rapportés. Une métaplasie malpighienne revêtant les mêmes caractéristiques histologiques que la SMN a été décrite dans les glandes séro-muqueuses des fosses nasales, des sinus [23,[119][120][121][122][123], du larynx [124][125][126], de la trachée [127][128][129], des glandes mammaires [130] et des glandes sudorales [131][132][133]. Bien que les termes d'adénométaplasie et de syringométaplasie soient plus appropriés, car les glandes impliquées ne sont pas des glandes salivaires, le diagnostic de « sialométaplasie » a été retenu dans ces localisations rares.…”

Section: Discussionunclassified

La sialométaplasie nécrosante : revue systématique de la littérature

Aubies-Trouilh¹,

Fricain²

2012

Med Buccale Chir Buccale

View full text Add to dashboard Cite

Résumé -Objectif :Répertorier les caractéristiques épidémiologiques, étiopathogéniques, cliniques, histologiques et thérapeutiques de la sialométaplasie nécrosante (SMN). Results: NSM is an uncommon benign disease of salivary glands. Usually, NSM affects the minor salivary glands of the hard palate. It occurs primarily in adults, NSM is manifested by a sharply demarcated crater-like palatal ulcer. Although the etiology is uncertain, the lesion heals spontaneously. Conclusion: Dental surgeon has to know this lesion because of the risk of histological and clinical confusion with malignant lesions which may lead to mutilating radical treatment.

show abstract

Section: Discussionunclassified

La sialométaplasie nécrosante : revue systématique de la littérature

Aubies-Trouilh¹,

Fricain²

2012

Med Buccale Chir Buccale

View full text Add to dashboard Cite

show abstract

“…In 34/54 (63%) of the reported cases including ours, NEH developed in patients with acute myelogenous leukemia and most patients were treated with cytarabine and anthracyclins [1, 2, 4, 5, 7, 10, 12, 13, 15, 16, 17, 18, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 33, 34, 38]. However, NEH also develop in patients with other underlying malignancies, such as Hodgkin’s disease, non-Hodgkin’s lymphoma, chronic lymphocytic leukemia, acute lymphoblastic leukemia and cancers [3, 4, 7, 8, 9, 10, 11, 13, 28, 31].…”

Section: Discussionmentioning

confidence: 92%

“…Fifty-three cases have been reported until now in the literature and this condition is mainly found in patients receiving chemotherapy regimens with anthracyclins or cytarabine for acute myelogenous leukemia [1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38]. This finding has led some authors to hypothesize that NEH could represent a peculiar reaction to cytotoxic drugs excreted in sweat.…”

Section: Introductionmentioning

confidence: 99%

Recurrent Neutrophilic Eccrine Hidradenitis in an HIV-1-Infected Patient

2000

View full text Add to dashboard Cite

Most cases of neutrophilic eccrine hidradenitis (NEH) have been reported in patients receiving chemotherapy for acute myelogenous leukemia or other malignant diseases. We report the case of an HIV-1-infected patient who presented several and strikingly similar episodes of NEH without any medication as well as another one after the first course of chemotherapy for a B-cell non-Hodgkin’s lymphoma. This case strengthens the hypothesis that NEH may occur in different situations, as reported for other neutrophilic dermatoses.

show abstract

“…1,34 Similarly to neutrophilic eccrine hidradenitis, eccrine squamous syringometaplasia also has an unspecific clinical presentation, constituted by erythematous maculae, papules and papular plaques or vesicles, localized or disseminated. 35 Lesions develop between 2 to 39 days after the start of chemotherapy and improve spontaneously after 4 weeks. 36 The diagnosis is histopathological, characterized by the presence of squamous metaplasia of the eccrine glands in the papillary dermis.…”

Section: Eccrine Squamous Syringometaplasiamentioning

confidence: 99%

Reações tegumentares adversas relacionadas aos agentes antineoplásicos: parte I

Sanches

Brandt

Moure

et al. 2010

An. Bras. Dermatol.

View full text Add to dashboard Cite

Abstract:The local and systemic treatment of tumors can cause changes in the skin, mucous membranes, hair and nails. Accurate diagnosis and appropriate treatment of side effects require knowledge about the patterns of the most common adverse reactions to drugs the patient may be using. The dermatologist must be familiar with the manifestations of certain soft tissue neoplasms, as well as with the adverse mucocutaneous forms of cancer treatment. Keyword s: Chemotherapy, adjuvant; Drug therapy; Drug therapy, combination; Skin; Skin abnormalities; Skin pigmentation Resumo: O tratamento local e sistêmico das neoplasias pode causar alterações na pele, membranas mucosas, cabelos e unhas. O diagnóstico preciso e o tratamento adequado destes efeitos colaterais requerem conhecimento dos padrões das reações adversas mais comuns para as medicações que o paciente está utilizando. O dermatologista deve estar familiarizado com as manifestações tegumentares das neoplasias, bem como com os efeitos adversos mucocutâneos dos tratamentos antineoplásicos.

show abstract

Eccrine squamous syringometaplasia. A cutaneous sweat gland reaction in the histologic spectrum of 'chemotherapy-associated eccrine hidradenitis' and 'neutrophilic eccrine hidradenitis'

Cited by 69 publications

References 22 publications

La sialométaplasie nécrosante : revue systématique de la littérature

La sialométaplasie nécrosante : revue systématique de la littérature

Recurrent Neutrophilic Eccrine Hidradenitis in an HIV-1-Infected Patient

Reações tegumentares adversas relacionadas aos agentes antineoplásicos: parte I

Contact Info

Product

Resources

About